| Autor: |
Zappe K; Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria., Pühringer K; Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria., Pflug S; Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria., Berger D; Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria., Weis S; Division of Neuropathology, Department of Pathology and Molecular Pathology, Kepler University Hospital GmbH, Johannes Kepler University, 4040 Linz, Austria., Spiegl-Kreinecker S; Department of Neurosurgery, Kepler University Hospital GmbH, Johannes Kepler University, 4040 Linz, Austria., Cichna-Markl M; Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, 1090 Vienna, Austria. |
| Abstrakt: |
The response of glioblastoma (GBM) patients to the alkylating agent temozolomide (TMZ) vitally depends on the expression level of the repair protein O6-methylguanine-DNA methyltransferase (MGMT). Since MGMT is strongly regulated by promoter methylation, the methylation status of the MGMT promoter has emerged as a prognostic and predictive biomarker for GBM patients. By determining the methylation levels of the four enhancers located within or close to the MGMT gene, we recently found that enhancer methylation contributes to MGMT regulation. In this study, we investigated if methylation of the four enhancers is associated with SNP rs16906252, TERT promoter mutations C228T and C250T, TERT SNP rs2853669, proliferation index Ki-67, overall survival (OS), age, and sex of the patients. In general, associations with genetic variants, clinical parameters, and demographic characteristics were caused by a complex interplay of multiple CpGs in the MGMT promoter and of multiple CpGs in enhancer regions. The observed associations for intragenic enhancer 4, located in intron 2 of MGMT , differed from associations observed for the three intergenic enhancers. Some findings were restricted to subgroups of samples with either methylated or unmethylated MGMT promoters, underpinning the relevance of the MGMT promoter status in GBMs. |
